Clinical Trial Update: FMT+ QL1706+Bevacizumab+ XELOX as First-line Treatment for Advanced MSS-type Colon Cancer With Liver Metastasis [Phase 2]

View source ↗

Summary

A Phase 2 trial update on first-line treatment for advanced MSS colorectal cancer with liver metastases using a combination of fecal microbiota transplant, QL17…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Bevacizumab (bevacizumab)
• Capecitabine (capecitabine)
• FMT (fecal microbiota transplant) (Fecal microbiota transplant)
• OXALIPLATIN (Oxaliplatin)
• QL1706

Snippet

Sponsor: Hua Jiang | Conditions: Colon Cancer Liver Metastases | Phase 2 | Status: RECRUITING